German stocks traded lower on Monday, with Bayer AG shares plunging to a 12-year low after aborting a large late-stage trial testing a new anti-clotting drug due to lack of efficacy.
Read Full Story
- What is Meant by “Discovery” in Sales? A Strategy for Building Trust and Driving Conversions - March 12, 2025
- How to Sell a Small Business: A Starter Guide for Business Owners - February 3, 2025
- European Shares Drift Lower Amid France’s Debt Woes - November 27, 2024